Filter By Unselect All

Sub Category Unselect

Country Unselect

Companies Unselect See All

Selected Filter(s): Reset All

  • Category
  • Reset
  • Sub Category
  • Reset
  • Country
  • Reset

Contact

Phase I Clinic Capabilities

Clinical Trials >> Early Clinical / Phase I-IIa >> Phase I / IIa

PPD’s Phase I clinic conducts approximately 100 studies per year and has sufficient capacity to carry out multiple studies of varying design simultaneously. Research-experienced, board-certified physicians serve as principal investigators for Phase I studies. Secure and confidential drug

Contact

Bioequivalence Studies

Clinical Trials >> Early Clinical / Phase I-IIa >> Phase I / IIa

With more than 40 years of experience in performing bioequivalence studies, our clinical unit in Bloemfontein, South Africa, is a center of excellence. It is strategically placed in the perfect location for these trials a lower cost and fast start-up environment.

Contact

Early Development Clinical Research Services

Clinical Trials >> Early Clinical / Phase I-IIa >> Phase I / IIa

Program services offered by both clinics range from medical writing, clinical conduct and data management to monitoring, biostatistics and clinical pharmacology.

Contact

Supporting Drug Development at Phase I & II

Clinical Trials >> Early Clinical / Phase I-IIa >> Phase I / IIa

MPI Research is a full early-stage drug development CRO that partners with biopharmaceutical, biotechnology, medical device, animal health, and chemical industries to advance global healthcare. MPI Research supports all phases of the drug development pathway, ranging from target identification

Contact

Clinical PK/PD and Pharmacometrics Services

Clinical Trials >> Early Clinical / Phase I-IIa >> Pharmacokinetics / Pharmacodynamics / Pharmacometrics

PAREXEL’s global team of experienced clinical pharmacokineticists and pharmacometricians offer unsurpassed expertise in Clinical PK/PD and Pharmacometrics, from pre-clinical to Phase III studies.

Contact

Early Phase Clinical Trials

Clinical Trials >> Early Clinical / Phase I-IIa >> Phase I / IIa

We have a speciality in early phase trials involving healthy volunteers. Early phase trials may have many factors that must be considered to achieve the research goals.

Contact

Phase 1 Clinical Pharmacology Study

Clinical Trials >> Early Clinical / Phase I-IIa >> Phase I / IIa

Quotient has the experience and expertise to seamlessly deliver your studies with the highest quality service and speed to clinical data. If you need a complete service including data management, data analysis, statistics and medical writing, Quotient is your answer.

Contact

ADME / Mass Balance

Clinical Trials >> Early Clinical / Phase I-IIa >> Pharmacokinetics / Pharmacodynamics / Pharmacometrics

The ADME (Absorption, Distribution, Metabolism and Excretion) Suite includes new state-of-the-art equipment and laboratory space to perform on-site scintillation counting allowing for radioactivity recovery results to be delivered in real-time.

Contact

Phase 1 Clinical Trials

Clinical Trials >> Early Clinical / Phase I-IIa >> Phase I / IIa

PAREXEL® has the global SOPs to perform Phase 1 clinical trials in harmony across multiple locations, and stands committed to the success of your journey.

Contact

Phase lla

Clinical Trials >> Early Clinical / Phase I-IIa >> Phase I / IIa

PAREXEL® has developed an integrated and adaptive approach that supports Phase IIa outcomes.

PharmaCompass >>